Browse our latest Cancer Biology articles

Page 40 of 88
    1. Cancer Biology
    2. Cell Biology

    Cyclin F drives proliferation through SCF-dependent degradation of the retinoblastoma-like tumor suppressor p130/RBL2

    Taylor P Enrico, Wayne Stallaert ... Michael J Emanuele
    The SCF-family of ubiquitin ligases regulates the key cancer proliferation node by controlling the degradation of RB-like tumor suppressor RBL2/p130.
    1. Cancer Biology
    2. Cell Biology

    Rpl24Bst mutation suppresses colorectal cancer by promoting eEF2 phosphorylation via eEF2K

    John RP Knight, Nikola Vlahov ... Owen J Sansom
    Signalling that maintains rapid translation elongation in KRAS-mutant colorectal cancer models can be targeted by mutation of the ribosomal protein RPL24 to suppress tumour proliferation.
    1. Cancer Biology

    Concomitant activation of GLI1 and Notch1 contributes to racial disparity of human triple negative breast cancer progression

    Sumit Siddharth, Sheetal Parida ... Dipali Sharma
    Elucidation of GLI1-Notch1 axis as key determinant of racial disparity in TNBC growth in African American and White American women.
    1. Cancer Biology
    2. Genetics and Genomics

    Mutations: When oncogenes do not cause cancer

    Jessica Shiu, Arthur D Lander
    Environmental cues, not oncogene-induced senescence, may stop melanocytes with an activating mutation in the BRAF gene from turning into melanoma.
    Version of Record
    Insight
    1. Cancer Biology
    2. Computational and Systems Biology

    Investigating the replicability of preclinical cancer biology

    Timothy M Errington, Maya Mathur ... Brian A Nosek
    A project to repeat experiments from high-impact papers in cancer biology found that the effects observed in replications were frequently weaker than, or inconsistent with, the effects reported in the original papers.
    1. Cancer Biology

    Science Forum: Is preclinical research in cancer biology reproducible enough?

    Patrick Bodilly Kane, Jonathan Kimmelman
    Results from the Reproducibility Project: Cancer Biology provide a picture of the rate of false positives in cancer preclinical research, but it is still not clear if research in this field is less reproducible than it should be.
    1. Cancer Biology

    Experiments from unfinished Registered Reports in the Reproducibility Project: Cancer Biology

    Timothy M Errington, Alexandria Denis ... Lisa Young
    A project to repeat experiments from high-impact papers in cancer biology did not complete all replications, with challenges ranging from mundane reasons to unexpected methodological issues.
    1. Cancer Biology

    Reproducibility in Cancer Biology: What have we learned?

    Peter Rodgers, Andy Collings
    As the final outputs of the Reproducibility Project: Cancer Biology are published, it is clear that preclinical research in cancer biology is not as reproducible as it should be.
    1. Cancer Biology

    Reproducibility in Cancer Biology: Challenges for assessing replicability in preclinical cancer biology

    Timothy M Errington, Alexandria Denis ... Brian A Nosek
    A project to repeat experiments from high-impact papers in cancer biology encountered a series of challenges, many of which were caused by a lack of detail in the original papers.
    1. Biochemistry and Chemical Biology
    2. Cancer Biology

    Elevated FBXO45 promotes liver tumorigenesis through enhancing IGF2BP1 ubiquitination and subsequent PLK1 upregulation

    Xiao-Tong Lin, Hong-Qiang Yu ... Chuan-Ming Xie
    Using IGF2BP1-PLK1 axis as an example, targeting oncogenic signaling represents a direction treatment for HCC patients with high FBXO45 expression.